PrEP use increased between 2013 and 2023, according to a research letter published online in the Journal of the American Medical Association.

PrEP, or pre-exposure prophylaxis, was first approved by the FDA in 2012 to prevent people exposed to HIV from becoming ...

Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...

New IDWeek 2024 study reveals disparities in PrEP uptake across key U.S. populations. While overall PrEP usage has increased, ...